Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Intuitive Surgical: Trade-in Sales Data Helps Confirm Bullish Case
Motley Fool
Monday, January 28, 2013 - 10:12am
tags:
Intuitive Surgical, Da Vinci Surgical System
Takeda Diabetes Drug Succeeding Actos Wins FDA Approval
Bloomberg
Monday, January 28, 2013 - 10:11am
tags:
Takeda, diabetes, Actos, FDA
A Detailed Look At Abbvie
Seeking Alpha
Monday, January 28, 2013 - 10:07am
tags:
AbbVie
FDA announces approval of three new drugs to treat Type 2 diabetes
examiner.com
Sunday, January 27, 2013 - 11:35am
tags:
type 2 diabetes, Takeda, diabetes, alogliptin, Furiex Pharmaceuticals
FDA warns of liver injury risk associated with hyponatremia drug
Healio
Sunday, January 27, 2013 - 11:33am
tags:
hyponatremia, Samsca, Otsuka
AbbVie Sues Generic Drugmaker Sun Over Zemplar Patent
BusinessWeek
Sunday, January 27, 2013 - 11:32am
tags:
AbbVie, Sun Pharma, Zemplar, generics, lawsuits
Takeda Diabetes Drug Succeeding Actos Wins FDA Approval
Bloomberg
Sunday, January 27, 2013 - 11:25am
tags:
Takeda, diabetes, type 2 diabetes, Actos, alogliptin, Furiex Pharmaceuticals
A Detailed Look At Abbvie
Seeking Alpha
Sunday, January 27, 2013 - 11:23am
tags:
AbbVie
5 Top Dow 30 Healthcare Stories of the Week
Wall Street Cheat Street
Sunday, January 27, 2013 - 11:22am
tags:
JNJ, Pfizer, Merck, IBM
Can Biologics Make You Rich?
Motley Fool
Sunday, January 27, 2013 - 11:21am
tags:
AbbVie, Amgen, Biogen Idec, JNJ, Roche
This Week in Biotech: Part 2
Motley Fool
Sunday, January 27, 2013 - 11:20am
tags:
Roche, Novartis, Impax Laboratories, MAP Pharmaceuticals, Allergan
Bristol-Myers Squibb Company Earnings Call Insights: Tax Rate Drop and PD-1 Readout
Wall Street Cheat Street
Sunday, January 27, 2013 - 11:19am
tags:
Bristol-Myers Squibb, earnings
Which Biotech Company Will Be Bought Out Next?
Motley Fool
Sunday, January 27, 2013 - 11:18am
tags:
Theravance, GSK, Astellas, Vivus, Eli Lilly, Immunogen, Roche, M&A
Celgene 2017 Guidance: 2 Times 2013 Revenue
Seeking Alpha
Sunday, January 27, 2013 - 11:15am
tags:
Celgene
China Biotech In Review: 2012 China Life Science VC, M&A, And Partnering Climb
Seeking Alpha
Sunday, January 27, 2013 - 11:11am
tags:
Zhejiang Hisun Pharma, Simcere, Chongqing Huapont Pharma, Xceleron
Bristol-Myers Squibb and 3 Top Pharma Stocks with Earnings Investors Must See
Wall Street Cheat Street
Sunday, January 27, 2013 - 11:09am
tags:
Bristol-Myers Squibb, earnings, Amgen, Celgene Corporation, AmerisourceBergen
This Week in Biotech: Part 1
Motley Fool
Sunday, January 27, 2013 - 11:07am
tags:
Cellgene, Eli Lilly, Biogen Idec, Vanda, Celsion
Earnings Season: It's All About Expectations
Motley Fool
Saturday, January 26, 2013 - 11:59am
tags:
Bristol-Myers Squibb, AstraZeneca
Johnson & Johnson: Valuation, Growth Prospects, And Dividend Growth All Point To A Further Upside
Seeking Alpha
Saturday, January 26, 2013 - 11:58am
tags:
JNJ, earnings
Breaking Down Health Care's Biggest Earnings Report
Motley Fool
Saturday, January 26, 2013 - 11:57am
tags:
JNJ, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.